Week in Review: San Diego crackdown, WA eyes organic marijuana & Britain says yes to CBD
By Bart Schaneman and John Schroyer San Diego targets illegal dispensaries while educating consumers about legit operations, Washington…
News October 14
Latest In: GW Pharmaceuticals
Week in Review: MassRoots’ woes, GW Pharma’s good news & pro-legalization polls
By Omar Sacirbey and John Schroyer MassRoots lands in financial hot water, GW Pharmaceuticals takes a step closer…
News September 30GW Pharma’s latest clinical trial successful, stock soars
British cannabis company GW Pharmaceuticals has conducted a successful clinical trial in which it treated epileptic children with…
News September 27Medical Cannabis Company GW Pharma’s Stock Again Jumps
GW Pharmaceuticals – a publicly traded British medical cannabis company conducting clinical trials to determine how effective its…
News June 27
GW Pharmaceuticals Could Make Major Splash in U.S. Cannabis Industry
By Omar Sacirbey A British company that develops cannabis-based medicine is on the verge of a major breakthrough…
News March 30Study Results Send GW Pharma’s Stock Soaring
A British maker of cannabis-based drugs revealed some sorely needed good news on Monday, announcing that an epilepsy medicine…
News March 14DEA Allows Drug Company to Import Cannabis
A drug delivery and technology company has received approval from the U.S. Drug Enforcement Administration to import marijuana…
News December 14
Week in Review: Strong Illinois MMJ Sales, Positive Merrill Lynch Report & British Firm’s U.S. Expansion
By John Schroyer and Omar Sacirbey Illinois medical cannabis sales start off on a positive note, Merrill Lynch…
News December 11GW Pharma Boosts Production in Expectation of FDA Approval
GW Pharmaceuticals is reportedly increasing its manufacturing capacity for medical marijuana and a specific cannabis-based drug it has…
News December 9Featured
1
Latest Sponsored
